TGTX CIK: 1001316

TG Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.90
FY22:
2.52
FY23:
220
FY24:
291
FY25:
516
(positive)
Change from FY21 to FY25
millions USD
FY21:
−346
FY22:
−193
FY23:
20.6
FY24:
41.9
FY25:
123
(positive)
Change from FY21 to FY25
millions USD
FY21:
−342
FY22:
–
FY23:
26.1
FY24:
49.9
FY25:
134
(positive)
Change from FY21 to FY25
millions USD
FY21:
−348
FY22:
−224
FY23:
13.1
FY24:
25.6
FY25:
107
(positive)
Change from FY21 to FY25
millions USD
FY21:
−348
FY22:
−224
FY23:
12.7
FY24:
23.4
FY25:
447

All amounts in millions USD Data sources:SEC EDGARTwelve Data